H 4730
An Act establishing a Naloxone Purchase Trust fund
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill creates a trust fund to support the purchase, storage, and distribution of naloxone, a medication used to reverse opioid overdoses, throughout the Commonwealth of Massachusetts. The fund will be financed through various sources, including contributions from third-party payers and revenue from managed care organizations. Naloxone will be provided to healthcare facilities and individuals with a history of opioid use or overdose. The bill also modifies existing definitions and revenue streams within the state’s healthcare finance system to support the new trust fund.
Key provisions
- Establishes the Naloxone Purchase Trust Fund to finance opioid antagonist distribution.
- Defines key terms related to opioid antagonists and distribution channels.
- Specifies funding sources for the trust fund, including contributions from payers and managed care organizations.
- Outlines eligible recipients of naloxone, including healthcare facilities and individuals with opioid use disorder history.
- Modifies existing definitions related to managed care organization services assessment.
- Adjusts revenue streams within the state’s healthcare finance system to contribute to the trust fund.
- Requires the Department of Public Health to adopt rules for the universal purchase and distribution system.
- Mandates annual reporting on fund activities to legislative committees.
Who is affected
- Healthcare facilities (hospitals, emergency departments, substance use disorder treatment facilities, community health centers)
Sponsors
Official sponsors from legislative records.
Primary sponsor
Joint Committee on Public Health
Cosponsors
Christine P. Barber
Christopher Hendricks
David Henry Argosky LeBoeuf
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.4730 194th (Current)
An Act establishing a Naloxone Purchase Trust fund
View Text Print Preview Download PDF
Bill Information
Bill Information
Sponsor: Joint Committee on Public Health Status: Referred to Joint Committee on Health Care Financing
Tabs
Bill History Cosponsors Committee Vote Committee Summary
Bill History
Displaying 5 actions for Bill H.4730
| Date | Branch | Action |
| 11/13/2025 | House | Reported from the committee on Public Health |
| 11/13/2025 | House | New draft of H2535 |
| 11/13/2025 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 12/8/2025 | House | Reporting date extended to Wednesday, March 18, 2026 |
| 3/19/2026 | House | Reporting date extended to Monday, June 15, 2026 |
Similar Bills
H.2535 194th (Current)
An Act establishing a Naloxone Purchase Trust fund
S.1551 194th (Current)
An Act establishing a naloxone purchase trust fund
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.